Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
PDGFR
>>
Phase 3
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
7
14
21
28
35
42
49
56
63
70
famitinib
(SHR 1020) / Jiangsu Hengrui Pharma
Rydapt
(midostaurin) / Novartis
dovitinib
(TKI258) / Novartis, Oncoheroes
Kinaction
(masitinib) / AB Science
vatalanib
(PTK787) / Novartis, Bayer
sitravatinib
(MGCD516) / BeiGene
Balversa
(erdafitinib) / J&J
Fotivda
(tivozanib) / Kyowa Kirin, Jazz, LG Chem
lucitanib
(E 3810) / Clovis, Servier
motesanib
(AMG 706) / Takeda
Fumena
(vorolanib) / Tyrogenex, Betta Pharma
Lartruvo
(olaratumab) / Eli Lilly
crenolanib
(ARO-002) / AROG
linifanib
(ABT-869) / AbbVie
chiauranib
(CS 2164) / Chipscreen
Fovista
(pegpleranib) / Roche, Astellas
Qinlock
(ripretinib) / Deciphera
seralutinib
(GB002) / Gossamer Bio
Evizon
(squalamine) / NeuBase Therap
Axpaxli
(intravitreal axitinib implant) / Ocular Therap
imatinib dry powder
(AV-101) / Aerovate Therap
orantinib
(TSU-68) / Otsuka, Pfizer
CBT-001
/ Cloudbreak Therap
HyNap-Sora
(sorafenib nanoparticle) / Xspray Pharma
